Chromadex Corp
NASDAQ:CDXC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Chromadex Corp
Cash & Cash Equivalents
Chromadex Corp
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Chromadex Corp
NASDAQ:CDXC
|
Cash & Cash Equivalents
$44.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
19%
|
CAGR 10-Years
27%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash & Cash Equivalents
$3.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
15%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash & Cash Equivalents
$5.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
24%
|
|
|
Waters Corp
NYSE:WAT
|
Cash & Cash Equivalents
$587.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash & Cash Equivalents
$1.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash & Cash Equivalents
$2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
Chromadex Corp
Glance View
Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.
See Also
What is Chromadex Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
44.5m
USD
Based on the financial report for Dec 31, 2024, Chromadex Corp's Cash & Cash Equivalents amounts to 44.5m USD.
What is Chromadex Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
27%
Over the last year, the Cash & Cash Equivalents growth was 64%. The average annual Cash & Cash Equivalents growth rates for Chromadex Corp have been 16% over the past three years , 19% over the past five years , and 27% over the past ten years .
